Laverock Therapeutics
Company Type: Therapeutics
Main focus: Development of gene-silencing platform for the creation of programmable advanced therapies
Company stage: Pre-clinical
Diseases: Regenerative medicine and oncology
Genome-editing tool: Gene editing induced gene silencing (GEiGS) technology
Funding stage: Seed
Location: Stevenage, UK
Website: https://www.laverocktx.com
Pipeline: https://www.laverocktx.com/therapeutics
Partners:
Laverock Therapeutics is a pre-clinical stage company based in Steveage, UK, that is developing a unique gene-silencing platform for the creation of programmable advanced therapies. The company was established in 2021 to commercialise the gene-editing induced gene silencing (GEiGS) technology for human therapeutic applications. The company is currently focusing on two core disease areas – regenerative medicine and oncology.